Related Experiment Videos

In vitro synthesis of M and Z forms of human alpha 1-antitrypsin

FEBS Letters
|November 1, 1982
PubMed

Insights

Alpha 1-antitrypsin deficiency (PiZZ) is caused by faulty protein processing, not synthesis issues. Intracellular Z protein buildup, not low protease inhibitor levels, likely drives liver damage in PiZZ individuals.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Alpha 1-antitrypsin deficiency is a genetic disorder.
  • The Z variant (PiZZ) is associated with reduced plasma levels of alpha 1-antitrypsin.
  • Liver pathology is observed in individuals with the Z variant.

Purpose of the Study:

  • To investigate the synthesis of alpha 1-antitrypsin in PiZZ versus PiMM subjects.
  • To determine if the deficiency is due to impaired protein synthesis or post-synthesis processing.
  • To elucidate the primary cause of liver pathology in alpha 1-antitrypsin deficiency.

Main Methods:

  • mRNA extraction from autopsy liver samples of PiZZ and PiMM individuals.
  • In vitro synthesis of alpha 1-antitrypsin using a wheat germ cell-free system.

Main Results:

  • Equivalent synthesis of alpha 1-antitrypsin was observed from both PiZZ and PiMM mRNA preparations.
  • This indicates that the protein is synthesized effectively in PiZZ individuals.

Conclusions:

  • The plasma deficiency of alpha 1-antitrypsin in PiZZ is likely due to impaired protein processing and secretion, not synthesis.
  • Intracellular accumulation of the Z protein, rather than low protease inhibitor levels, is the probable cause of liver pathology.

Related Concept Videos